IN8bio, Inc., a clinical-stage biopharmaceutical company specializing in gamma-delta T cell therapies, has reported strong progress in its Phase 1 and Phase 2 clinical programs, showing significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback